Step Pharma, Sas
Clinical trials sponsored by Step Pharma, Sas, explained in plain language.
-
New hope for blood cancer patients who fail standard therapy
Disease control Recruiting nowThis early-stage trial tests a new drug called STP938 in 20 adults with high risk essential thrombocythaemia (ET) whose current treatment (hydroxycarbamide) no longer works or causes side effects. The main goal is to see if STP938 safely lowers high platelet counts. Participants …
Phase: PHASE1 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated May 26, 2026 06:30 UTC
-
New drug STP938 enters early human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called STP938 in about 70 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and how the body processes it. A special focus is on ovarian cancers missing a specifi…
Phase: PHASE1 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for tough lymphomas: experimental drug STP938 enters human trials
Disease control Recruiting nowThis study tests a new drug called STP938 in adults with B-cell or T-cell lymphoma that has returned or not responded to at least two prior treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 180 participants will take the drug alone, first in…
Phase: PHASE1, PHASE2 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated May 18, 2026 12:03 UTC